267 related articles for article (PubMed ID: 10081502)
1. Progress in gene therapy for chronic granulomatous disease.
Malech HL
J Infect Dis; 1999 Mar; 179 Suppl 2():S318-25. PubMed ID: 10081502
[TBL] [Abstract][Full Text] [Related]
2. Expansion of genetically corrected neutrophils in chronic granulomatous disease mice by cotransferring a therapeutic gene and a selective amplifier gene.
Hara T; Kume A; Hanazono Y; Mizukami H; Okada T; Tsurumi H; Moriwaki H; Ueda Y; Hasegawa M; Ozawa K
Gene Ther; 2004 Sep; 11(18):1370-7. PubMed ID: 15229634
[TBL] [Abstract][Full Text] [Related]
3. Progress toward effective gene therapy for chronic granulomatous disease.
Malech HL; Choi U; Brenner S
Jpn J Infect Dis; 2004 Oct; 57(5):S27-8. PubMed ID: 15507764
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated gene transfer into monocyte-derived macrophages of patients with X-linked chronic granulomatous disease: ex vivo correction of deficient respiratory burst.
Schneider SD; Rusconi S; Seger RA; Hossle JP
Gene Ther; 1997 Jun; 4(6):524-32. PubMed ID: 9231068
[TBL] [Abstract][Full Text] [Related]
5. Lentivirus-mediated gene transfer of gp91phox corrects chronic granulomatous disease (CGD) phenotype in human X-CGD cells.
Saulnier SO; Steinhoff D; Dinauer MC; Zufferey R; Trono D; Seger RA; Hossle JP
J Gene Med; 2000; 2(5):317-25. PubMed ID: 11045425
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for chronic granulomatous disease.
Kume A; Dinauer MC
J Lab Clin Med; 2000 Feb; 135(2):122-8. PubMed ID: 10695656
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy of chronic granulomatous disease (CGD) by gene transfer into hematopoietic stem cells.
Zentilin L; Tafuro S; Serra C; Falaschi A; Giacca M
Ann Ist Super Sanita; 1998; 34(4):447-55. PubMed ID: 10234875
[TBL] [Abstract][Full Text] [Related]
8. Stable long-term gene correction with low-dose radiation conditioning in murine X-linked chronic granulomatous disease.
Goebel WS; Pech NK; Dinauer MC
Blood Cells Mol Dis; 2004; 33(3):365-71. PubMed ID: 15528159
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for chronic granulomatous disease.
Kang EM; Malech HL
Methods Enzymol; 2012; 507():125-54. PubMed ID: 22365772
[TBL] [Abstract][Full Text] [Related]
10. Chronic granulomatous disease: towards gene therapy.
Thrasher A; Segal A; Casimir C
Immunodeficiency; 1993; 4(1-4):327-33. PubMed ID: 8167728
[TBL] [Abstract][Full Text] [Related]
11. Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease.
Björgvinsdóttir H; Ding C; Pech N; Gifford MA; Li LL; Dinauer MC
Blood; 1997 Jan; 89(1):41-8. PubMed ID: 8978275
[TBL] [Abstract][Full Text] [Related]
12. Enhancer-deleted retroviral vectors restore high levels of superoxide generation in a mouse model of CGD.
Schwickerath O; Brouns G; Thrasher A; Kinnon C; Roes J; Casimir C
J Gene Med; 2004 Jun; 6(6):603-15. PubMed ID: 15170731
[TBL] [Abstract][Full Text] [Related]
13. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
[TBL] [Abstract][Full Text] [Related]
14. The search for a genetic defect in Polish patients with chronic granulomatous disease.
Jurkowska M; Kurenko-Deptuch M; Bal J; Roos D
Arch Immunol Ther Exp (Warsz); 2004; 52(6):441-6. PubMed ID: 15577746
[TBL] [Abstract][Full Text] [Related]
15. Chronic granulomatous disease. Molecular genetics.
Dinauer MC; Orkin SH
Hematol Oncol Clin North Am; 1988 Jun; 2(2):225-40. PubMed ID: 3292508
[TBL] [Abstract][Full Text] [Related]
16. Virulence of catalase-deficient aspergillus nidulans in p47(phox)-/- mice. Implications for fungal pathogenicity and host defense in chronic granulomatous disease.
Chang YC; Segal BH; Holland SM; Miller GF; Kwon-Chung KJ
J Clin Invest; 1998 May; 101(9):1843-50. PubMed ID: 9576747
[TBL] [Abstract][Full Text] [Related]
17. Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells.
Moreno-Carranza B; Gentsch M; Stein S; Schambach A; Santilli G; Rudolf E; Ryser MF; Haria S; Thrasher AJ; Baum C; Brenner S; Grez M
Gene Ther; 2009 Jan; 16(1):111-8. PubMed ID: 18784749
[TBL] [Abstract][Full Text] [Related]
18. [Gene therapy for inherited diseases using heamatopoietic stem cells--gene therapy for patients with chronic granulomatous disease].
Nunoi H; Ishibashi F
Hum Cell; 1999 Sep; 12(3):103-8. PubMed ID: 10695016
[TBL] [Abstract][Full Text] [Related]
19. Delineation of the phagocyte NADPH oxidase through studies of chronic granulomatous diseases of childhood.
Gallin JI
Int J Tissue React; 1993; 15(3):99-103. PubMed ID: 8188451
[TBL] [Abstract][Full Text] [Related]
20. Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients.
Wolach B; Gavrieli R; de Boer M; Gottesman G; Ben-Ari J; Rottem M; Schlesinger Y; Grisaru-Soen G; Etzioni A; Roos D
Clin Immunol; 2008 Oct; 129(1):103-14. PubMed ID: 18708296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]